The approval was given after its clinical trials on Covid-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medicine experts from AIIMS, among others, for treatment of cytokine release syndrome
from Hindustan Times - india https://ift.tt/2OrjhKB
No comments:
Post a Comment